TELADOC HEALTH INC.DL-001 WKN: A14VPK ISIN: US87918A1051 Kürzel: TDOC Forum: Aktien Thema: Hauptdiskussion

Hayde

Rein in den Aal

Gehe jetzt short auf diesen Schweineverein

Nichts intakt bin enttäuscht

Fazit: alles intakt.

Überragend aber so wie ich das sehe wird Q1 schlechter als erwartet

Erster Eindruck, Zahlen gut, Ausblick wie erwartet und damit nicht positiv überraschend

Zahlen sind doch gut oder?

Skimbo was willst mit so ne frage bezwecken, ernst gemeint kann sie ja nicht sein

Hammer zahlen

Average revenue per U.S. paid member increased to $2.49 in the fourth quarter of 2021, from $1.63 in the fourth quarter of 2020 and $2.40 in the third quarter of 2021. For Q1, the company expects revenue in the range of $565M to $571M vs. consensus of $589.09M and diluted EPS of -$0.60 to -$0.50 vs. consensus of -$0.43. For FY2022, the company expects revenue in the range of $2.55B to $2.65B vs. consensus of $2.57B and diluted EPS of -$1.60 to -$1.40 vs. consensus of -$1.62.

Teladoc Health GAAP EPS of -$0.07 beats by $0.51, revenue of $554.24M beats by $7.7M

Full year 2022 Revenue guidance of $2.55 to $2.65B, representing 25% to 30% growth

$TDOC Fourth quarter revenue grows 45% YoY to $554.2M and total visits increase 41% to 4.4M Full year revenue grows 86% YoY to $2.0327B and total visits increase 38% to 15.4M Full year cash flows from operations grew to $194M